Skip to content
DAT Supply Log in
Active ingredient · Gummy fit: good

Vitamin B3 (Niacin / Nicotinamide)

INCI: Nicotinamide

Nicotinamide, also known as niacinamide, is a water-soluble form of vitamin B3 used in food supplements. It is one of the most familiar and commercially understood gummy actives across EU and US markets. Under applicable claims framework, niacin (including nicotinamide) carries authorised claims for normal energy-yielding metabolism, nervous system function, psychological function, maintenance of normal skin, reduction of tiredness and fatigue, and normal mucous membranes.

  • Energy metabolism
  • Skin health
  • Nervous system
Build a formula with this ingredient
Vitamin B3 (Niacin / Nicotinamide)

At a glance

Definition
Nicotinamide, also known as niacinamide, is a water-soluble form of vitamin B3 used in food supplements. It is one of the most familiar and commercially understood gummy actives across EU and US markets. Under applicable claims framework, niacin (including nicotinamide) carries authorised claims for normal energy-yielding metabolism, nervous system function, psychological function, maintenance of normal skin, reduction of tiredness and fatigue, and normal mucous membranes.
Authorised wording (summary)
3 authorised statements — see "US structure-function statements" below.
Common gummy positionings
  • Energy and vitality
  • Beauty nutricosmetics
  • Daily wellness
  • Healthy ageing
  • Skin health support
Format suitability
Suitable for gummy formats — confirmed per project.

What it is

Nicotinamide is the amide form of niacin (vitamin B3), a water-soluble vitamin essential for cellular energy production and DNA repair. Unlike nicotinic acid, nicotinamide does not cause the flushing reaction at typical supplement doses, making it the preferred form for oral supplements including gummies.

Brands use nicotinamide in gummy formulations because it is heat-stable, soluble, and neutral-tasting at supplement doses. It supports a wide range of positioning angles from energy and vitality to beauty nutricosmetics and healthy ageing, backed by a robust set of EFSA-authorised health claims.

Origin and history

Nicotinamide was first identified in the 1930s as the anti-pellagra factor in the vitamin B complex. Pellagra, a disease caused by niacin deficiency, was widespread in populations subsisting on maize-based diets. The isolation and synthesis of nicotinamide revolutionised public health nutrition.

Today, nicotinamide is produced industrially through chemical synthesis from 3-picoline or via hydrolysis of nicotinonitrile. It is manufactured as a white crystalline powder with high purity and stability, suitable for direct incorporation into gummy and sachet formulations.

Scientific overview

Nicotinamide functions as a precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme central to cellular energy metabolism. NAD+ is required for redox reactions in glycolysis, the citric acid cycle, and oxidative phosphorylation. Adequate niacin status therefore supports normal energy-yielding metabolism and the reduction of tiredness and fatigue.

Bioavailability of nicotinamide from oral supplements is high, with rapid absorption in the small intestine. Unlike nicotinic acid, nicotinamide does not bind to the GPR109A receptor, which is responsible for the prostaglandin-mediated flushing reaction. This makes nicotinamide the preferred form for sustained supplementation at doses up to 900 mg per day.

From a manufacturing perspective, nicotinamide is heat-stable and water-soluble, with no known incompatibilities with common gummy excipients. It has a neutral taste profile at supplement doses, requiring no masking. The cost-per-mg is low, making it an economical active for mass-market formulations.

Why brands use Vitamin B3 (Niacin / Nicotinamide) in gummies

Nicotinamide is one of the most familiar and commercially understood gummy actives across EU and US markets. It supports multiple positioning angles including energy and vitality, beauty nutricosmetics (skin health), daily wellness, and healthy ageing. The EFSA-authorised claims for normal energy-yielding metabolism, nervous system function, and maintenance of normal skin provide strong, compliant pack-copy hooks.

From a formulation and manufacturing perspective, nicotinamide is straightforward to work with. It is heat-stable, soluble in gummy matrices, and neutral-tasting at supplement doses. The low cost-per-mg allows for flexible dosing from NRV levels (16 mg) up to higher levels for specific positioning. DAT confirms final formulation parameters per project.

For pack copy, brands can use any of the EFSA-authorised claims verbatim. No disease claims are permitted. Certification promises (vegan, kosher, halal, non-GMO, organic) depend on the selected raw material and supplier documentation. DAT confirms certification status per project and batch before final label claims. Shelf-life claims are confirmed per project with stability data.

Gummy formulation notes

Verified formulation reference. Final formulation, dose and on-pack copy are confirmed per project.

Gummy fit
Good
Heat stable
Yes
Soluble in matrix
Yes
Cost tier
Low

Forms available

  • Nicotinamide (pure crystalline powder)

Dosage reference

reference-intake target reviewed per market for niacin is 16 mg. Brand positioning typically ranges from 16 mg to 50 mg per serving. Higher doses (up to 900 mg) are used in some formulations but require careful regulatory review per market.

Taste & sensory

Neutral to mild taste at supplement doses.

Manufacturing notes

No specific formulation notes. Standard processing applies.

US structure-function statements

  • Niacin (as nicotinamide) helps convert food into cellular energy.Structure-function (DSHEA)
  • Niacin (as nicotinamide) supports normal nervous system function.Structure-function (DSHEA)
  • Niacin (as nicotinamide) helps maintain healthy skin.Structure-function (DSHEA)

Structure-function statements must appear with the FDA disclaimer in the same field of vision on the label. % Daily Value (DV) based on FDA 21 CFR 101.9.

Wording to avoid on pack copy

  • No disease claims — this product is not intended to diagnose, treat, cure, or prevent any disease.
  • Structure-function claims must be accompanied by the FDA disclaimer: 'These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.'
  • No certification promises on pack until confirmed per project and batch documentation.
  • No guaranteed shelf-life on pack until confirmed per project with stability data.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Structure-function claims are permitted under DSHEA (21 USC §343(r)(6)). Daily Value (DV) for niacin is 16 mg under FDA 21 CFR 101.9.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Studies & evidence

External peer-reviewed sources and regulatory opinions. Citations only — DAT does not endorse the publishers.

  1. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)·EFSA Journal·2009

  2. Bogan KL, Brenner C·Trends in Biochemical Sciences·2008

  3. Kirkland JB·Nutrients·2020

  4. Knip M, Douek IF, Moore WP, et al.·European Journal of Clinical Nutrition·2000

  5. European Commission·Official Journal of the European Union·2012

Catalogue match

Gummies featuring Vitamin B3 (Niacin / Nicotinamide)

Private-label gummy concepts where Vitamin B3 (Niacin / Nicotinamide) appears in the formula. Each opens to a product brief and quote route.

Synergies & conflicts

Pairs well with

Synergy data needs review.

Care when combining with

Conflict data needs review.

Project handoff

Build a formula with Vitamin B3 (Niacin / Nicotinamide)

Hand the brief over to the DAT portal. The wizard pre-fills the ingredient, target market, and route so the project review starts with the right context.

References

  1. Scientific Opinion on the substantiation of health claims related to niacin — EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), EFSA Journal, 2009.
  2. Niacin: an old drug with a new twist — Bogan KL, Brenner C, Trends in Biochemical Sciences, 2008.
  3. Nicotinamide: a vitamin that prevents pellagra and beyond — Kirkland JB, Nutrients, 2020.
  4. The safety of nicotinamide: a review — Knip M, Douek IF, Moore WP, et al., European Journal of Clinical Nutrition, 2000.
  5. Commission Regulation (EU) No 432/2012 establishing a list of permitted health claims made on foods — European Commission, Official Journal of the European Union, 2012.
Quick context request

Get manufacturing context

Drop your work email and a member of the DAT team will follow up with the right context for this concept. Project documents, certificates and pricing are released through the project workspace in the DAT portal.

You will receive a short confirmation email. Project documents (specification, batch-specific COA, packaging documents) are released through the project workspace in the DAT portal once a brief is in place.